Market Tracker

10/31 5:16pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

During the Trading Day
16.85 +0.28 / +1.69%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
16.85 0.00 / 0.00%
 
Volume: 15.7K
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close16.57
Today’s open16.85
Day’s range16.62 - 17.31
Volume1,100,509
Average volume (3 months)2,498,089
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)-55.96%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book30.16

Competitors

 Today’s
change
Today’s
% change
DYAXDyax Corp+0.08+0.65%
NKTRNektar Therapeutics-0.24-1.71%
ABCOAdvisory Board Co+0.71+1.34%
ARIAARIAD Pharmaceutical...-0.01-0.17%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
Chief Operating Officer &
Executive Vice President
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts